Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial

Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, indicating a technical UI release rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-24T06:17:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:20.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Glycogen storage disease II was updated to Glycogen storage disease, type II in the page's terminology (MeSH/keywords).
    Difference
    0.1%
    Check dated 2026-03-26T11:38:54.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:08:30.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:05.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous revision v3.4.1 was removed. The government-funding lapse notice was also removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:18:29.000Z thumbnail image

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.